| |
|
|
|
|
|
|
|||
|
Blood, 15 December 2005, Vol. 106, No. 13, pp. 4359-4366. Prepublished online as a Blood First Edition Paper on August 23, 2005August 25, 2005; DOI 10.1182/blood-2005-07-2806.
Submitted July 14, 2005
Department of Pediatrics, Second University of Naples, Naples, Italy * Corresponding author; email: silverio.perrotta{at}unina2.it.
The 911 amino acid band 3 (SLC4A1) is the major intrinsic membrane protein of red cells and is the principal Cl-/HCO3- exchanger. The N-terminal cytoplasmic domain of band 3 anchors the spectrin-based membrane skeleton to the lipid bilayer through its interaction with ankyrin and also binds glycolytic enzymes and hemoglobin. We identified a son of consanguineous marriage with severe anemia in association with marked deficiency of band 3 (12±4% of normal). Direct nucleotide sequencing of SLC4A1 gene demonstrated a single base substitution (T->C) at position +2 in the donor splice site of intron 2 resulting in the generation of a novel mutant protein. Biochemical characterization of the mutant protein showed that it lacked the first 11 N-terminal amino acids (Band 3 "Neapolis"). The expression of the mutant protein resulted in the complete absence of membrane bound aldolase and the mutant band 3 could not be tyrosine phosphorylated. The ability of the malarial parasite, P. falciparum, to invade these red cells was significantly decreased. The identification of a novel band 3 mutant and its structural and functional characterization enabled us to identify pivotal roles for the 11 N-terminal amino acids in several protein functions and, in turn, in red cell physiology.
Related Article in Blood Online:
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2005 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||